DFM:NIH Statistics

Total Valuation

DFM:NIH has a market cap or net worth of AED 418.69 million. The enterprise value is 446.98 million.

Market Cap	418.69M
Enterprise Value	446.98M

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	Jul 9, 2024

Share Statistics

Current Share Class	245.64M
Shares Outstanding	n/a
Shares Change (YoY)	+1.35%
Shares Change (QoQ)	+1.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	154.24M

Valuation Ratios

The trailing PE ratio is 13.72.

PE Ratio	13.72
Forward PE	n/a
PS Ratio	3.82
PB Ratio	0.68
P/TBV Ratio	0.83
P/FCF Ratio	29.79
P/OCF Ratio	28.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 31.80.

EV / Earnings	14.65
EV / Sales	4.08
EV / EBITDA	8.02
EV / EBIT	8.38
EV / FCF	31.80

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.04.

Current Ratio	2.80
Quick Ratio	2.59
Debt / Equity	0.04
Debt / EBITDA	0.45
Debt / FCF	1.78
Interest Coverage	18.26

Financial Efficiency

Return on equity (ROE) is 5.45% and return on invested capital (ROIC) is 5.45%.

Return on Equity (ROE)	5.45%
Return on Assets (ROA)	4.95%
Return on Invested Capital (ROIC)	5.45%
Return on Capital Employed (ROCE)	8.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.16
Inventory Turnover	3.52

Taxes

In the past 12 months, DFM:NIH has paid 213,915 in taxes.

Income Tax	213,915
Effective Tax Rate	0.67%

Stock Price Statistics

The stock price has increased by +2.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.46%
50-Day Moving Average	1.75
200-Day Moving Average	2.48
Relative Strength Index (RSI)	49.33
Average Volume (20 Days)	11,957

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DFM:NIH had revenue of AED 109.59 million and earned 30.51 million in profits. Earnings per share was 0.12.

Revenue	109.59M
Gross Profit	74.01M
Operating Income	53.37M
Pretax Income	32.05M
Net Income	30.51M
EBITDA	55.79M
EBIT	53.37M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

The company has 109.87 million in cash and 25.02 million in debt, giving a net cash position of 84.85 million.

Cash & Cash Equivalents	109.87M
Total Debt	25.02M
Net Cash	84.85M
Net Cash Per Share	n/a
Equity (Book Value)	615.22M
Book Value Per Share	2.05
Working Capital	96.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.94 million and capital expenditures -882,212, giving a free cash flow of 14.05 million.

Operating Cash Flow	14.94M
Capital Expenditures	-882,212
Free Cash Flow	14.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.53%, with operating and profit margins of 48.70% and 27.84%.

Gross Margin	67.53%
Operating Margin	48.70%
Pretax Margin	29.24%
Profit Margin	27.84%
EBITDA Margin	50.91%
EBIT Margin	48.70%
FCF Margin	12.82%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.97%.

Dividend Per Share	0.07
Dividend Yield	3.97%
Dividend Growth (YoY)	20.30%
Years of Dividend Growth	3
Payout Ratio	52.13%
Buyback Yield	-1.35%
Shareholder Yield	2.62%
Earnings Yield	7.29%
FCF Yield	3.36%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 5, 2025
Split Type	Forward
Split Ratio	1.06

Scores

Altman Z-Score	n/a
Piotroski F-Score	6